selected publications
-
Aberrant splicing in Huntington's disease accompanies disrupted TDP-43 activity and altered m6A RNA modification.
Nature neuroscience.
2025
Academic Article
GET IT
Times cited: 3 -
MAPK13 stabilization via m6A mRNA modification limits anticancer efficacy of rapamycin.
The Journal of biological chemistry.
2023
Academic Article
GET IT
Times cited: 1 -
m6A in the Signal Transduction Network.
Molecules and cells.
2022
Review
GET IT
Times cited: 24